BioViva treats first patient with gene therapy to reverse ageing

Some time ago I posted about BioViva, a new biotech company working on a cure for ageing led by Liz Parrish. In the video of the post, Liz appeared to be quite enthusiastic about what her company is doing and said that the company would hopefully have some results to show as soon as some point in 2016. Today, I stumbled upon an article on PrWeb, according to which “BioViva USA, Inc. has become the first company to treat a person with gene therapy to reverse biological aging, using a combination of two therapies developed and applied outside the United States of America. […] the subject is doing well and has resumed regular activities. Preliminary results will be evaluated at 5 and 8 months with full outcome expected at 12 months. The patient will then be monitored every year for 8 years […]. I suppose this is what Liz was talking about in the video, even though I haven’t find trace of the news on BioViva’s website (well, their site could use some work, I must say).

At any rate, I’m looking forward to hear again about this in a couple of months.

Ageing, meet Liz Parrish

Elizabeth Parrish, CEO of BioViva Sciences, gives an interesting talk on how her company plans to put an end to ageing: engineered genomics. I seem to understand that there were other talks at the same event, I think at least one held by Bill Andrews and possibly Aubrey de Grey; I will post them if I find them.